Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Infected or inflamed gingival tissue is the soft tissue of the gums in a state of active inflammation and often bacterial infection, typically seen in gingivitis or periodontitis. Clinically, it is characterized by redness, swelling, bleeding, and sometimes pain, resulting from an immune response to bacterial biofilms (dental plaque) adhering to the teeth. Inflammation results in cellular infiltration (neutrophils, lymphocytes, macrophages), tissue remodeling, and, if persistent, progressive destruction of the periodontal support structures. Untreated, this condition can precede or progress to periodontitis, potentially leading to tooth loss and may have systemic health implications including increased risk of cardiovascular disease, adverse pregnancy outcomes, and associations with neurodegenerative disorders.
Reduction of bacterial load (antibacterial agents/antiseptics disrupt plaque and bacterial biofilm); Immunomodulation (anti-inflammatories reduce tissue response).
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Infected gingival tissue.